Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells.
about
Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cellsγ-Actin plays a key role in endothelial cell motility and neovessel maintenanceMetronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma modelOptimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies.β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.Center of cancer systems biology second annual workshop--tumor metronomics: timing and dose level dynamicsMetronomics: towards personalized chemotherapy?Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.Long clinical benefit achieved in two patients with malignant paraganglioma treated by metronomic cyclophosphamide.Toxicity of metronomic cyclophosphamide chemotherapy in a UK population of cancer-bearing dogs: a retrospective study.Resistance to metronomic chemotherapy and ways to overcome it.Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition.Tumor dynamics in response to antiangiogenic therapy with oral metronomic topotecan and pazopanib in neuroblastoma xenografts.Role of vascular normalization in benefit from metronomic chemotherapy.Effects of low-dose cyclophosphamide with piroxicam on tumour neovascularization in a canine oral malignant melanoma-xenografted mouse model.Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.The metronomic therapy with prednisone, etoposide, and cyclophosphamide reduces the serum levels of VEGF and circulating endothelial cells and improves response rates and progression-free survival in patients with relapsed or refractory non-Hodgkin'
P2860
Q28553176-ECF2398A-8EB8-4593-8129-B817F57302D0Q30620886-A1E507D9-B6D1-4516-BF98-837E6FC5B777Q34173568-E8B71E68-DF49-44B0-BF9F-C0253275610AQ36265194-F2C276B0-9383-4D9A-904C-3C6DDCE3F600Q36959073-F0A8C25F-45A5-410F-91CF-BFB3AA5C72DBQ36966669-D51ACE2A-3F83-409D-94F9-A4E3952FFA44Q38218923-02FCFACE-FDEF-49BC-AA1B-A38E195CE7CEQ38638654-9D0D21E7-5505-4E92-953A-76BBEFC1BD3FQ39084619-FB7AAE79-7DF1-4676-8BEE-1923622E3964Q39108682-6477911B-6156-4D6A-AD99-1B71FBF87051Q40448516-941C10CB-2397-47DE-B92C-F380282CE254Q41515117-F7505F20-22E4-4678-A940-2A4171019DAEQ41912972-E49DEBAB-3946-4AE6-B484-83A8A660870EQ42318133-8D3E347D-0170-47BE-B4B1-CE36F489833BQ45881252-6F5A6481-5165-41CC-AA6A-0D3A0962396CQ48344360-948250AC-3F47-4DCF-8A82-9EE322928355Q49090942-BCE27D50-A0DF-4711-B0DF-1409B9820CA8
P2860
Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Concentration- and schedule-de ...... of vascular endothelial cells.
@ast
Concentration- and schedule-de ...... of vascular endothelial cells.
@en
type
label
Concentration- and schedule-de ...... of vascular endothelial cells.
@ast
Concentration- and schedule-de ...... of vascular endothelial cells.
@en
prefLabel
Concentration- and schedule-de ...... of vascular endothelial cells.
@ast
Concentration- and schedule-de ...... of vascular endothelial cells.
@en
P2093
P2860
P1433
P1476
Concentration- and schedule-de ...... of vascular endothelial cells.
@en
P2093
Diane Braguer
Eddy Pasquier
Janine Street
Karen L MacKenzie
Maria Kavallaris
Maria-Pia Tuset
Nicolas Andre
Snega Sinnappan
P2860
P2888
P304
P356
10.1007/S10456-012-9321-X
P577
2012-11-10T00:00:00Z